# Safety and Efficacy of Chlorthalidone in Type 1 Diabetes

> **NCT03325114** · PHASE2 · TERMINATED · sponsor: **University of Rochester** · enrollment: 1 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus
- Hypercalciuria

## Interventions

- **DRUG:** Chlorthalidone

## Key facts

- **NCT ID:** NCT03325114
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-28
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** COVID restrictions prohibit further study activies
- **Last updated:** 2021-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03325114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03325114, "Safety and Efficacy of Chlorthalidone in Type 1 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03325114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*